1. Home
  2. FND vs DNTH Comparison

FND vs DNTH Comparison

Compare FND & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Floor & Decor Holdings Inc.

FND

Floor & Decor Holdings Inc.

HOLD

Current Price

$56.21

Market Cap

5.3B

ML Signal

HOLD

Logo Dianthus Therapeutics Inc.

DNTH

Dianthus Therapeutics Inc.

HOLD

Current Price

$99.89

Market Cap

4.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FND
DNTH
Founded
2000
2015
Country
United States
United States
Employees
N/A
N/A
Industry
RETAIL: Building Materials
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.3B
4.5B
IPO Year
2014
2018

Fundamental Metrics

Financial Performance
Metric
FND
DNTH
Price
$56.21
$99.89
Analyst Decision
Buy
Strong Buy
Analyst Count
16
13
Target Price
$73.44
$121.00
AVG Volume (30 Days)
2.4M
1.1M
Earning Date
04-30-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
1.05
N/A
EPS
0.37
N/A
Revenue
$4,684,088,000.00
$2,036,000.00
Revenue This Year
$7.53
N/A
Revenue Next Year
$7.68
$29.48
P/E Ratio
$151.85
N/A
Revenue Growth
5.12
N/A
52 Week Low
$42.64
$18.08
52 Week High
$92.41
$102.37

Technical Indicators

Market Signals
Indicator
FND
DNTH
Relative Strength Index (RSI) 54.15 61.44
Support Level $53.94 $79.27
Resistance Level $56.49 N/A
Average True Range (ATR) 2.20 5.39
MACD -0.34 0.67
Stochastic Oscillator 47.16 82.57

Price Performance

Historical Comparison
FND
DNTH

About FND Floor & Decor Holdings Inc.

Floor & Decor Holdings Inc operates as a specialty retailer in the hard surface flooring market. Its stores offer a range of tile, wood, laminate, and natural stone flooring products, as well as decorative and installation accessories at everyday low prices. It appeals to a variety of customers including professional installers, commercial businesses, Do It Yourself (DIY) customers, and customers who buy the products for professional installation. Geographically, the group has a presence in the United States region and also offers its product through an e-commerce site. The company segments include retail segment and others.

About DNTH Dianthus Therapeutics Inc.

Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.

Share on Social Networks: